President Joe Biden demonstrates a receptive attitude towards the potential medical applications of psychedelic drugs, according to his younger brother, Frank Biden. In a recent interview on The Michael Smerconish Program, Frank Biden shed light on the President's viewpoint while also raising questions about the nation's readiness to embrace such treatments. He emphasized that his comments reflected a personal, brother-to-brother conversation.

Frank Biden expressed his belief that while his brother may be prepared to consider these alternative therapies, the broader American public might not yet be. He framed the issue within a larger context of societal consciousness, suggesting that greater awareness and understanding are needed to address challenges like addiction and foster unity. He highlighted the importance of recognizing our interconnectedness as a people.

Frank Biden, a recovering alcoholic, shared his personal interest in the therapeutic potential of psychedelics, driven by his own journey to sobriety. He has conducted extensive research on the subject. The use of psychedelic drugs, particularly psilocybin, the active compound in psychedelic mushrooms, is gaining traction among activists and users who believe in its potential to treat mental health conditions like addiction and depression.

Oregon and Colorado have taken steps to decriminalize or legalize the therapeutic use of psilocybin, reflecting a growing movement to explore alternative mental health treatments. Oregon's 2020 decision made it the first state to decriminalize hard drugs such as heroin and methamphetamine while simultaneously legalizing the therapeutic application of psilocybin mushrooms. Colorado has followed suit by decriminalizing the substance.

While the White House has not yet commented on Frank Biden's remarks, the conversation surrounding the potential medical uses of psychedelics continues to evolve. The Associated Press contributed to this report.